DNA methylation in thyroid tumorigenesis

Cancers

Volumn 3, Issue 2, 2011, Pages 1732-1743

  Stephen, Josena K ^a   Chitale, Dhananjay ^a   Narra, Vinod ^b   Chen, Kang Mei ^a   Sawhney, Raja ^a   Worsham, Maria J ^a  

^a HENRY FORD HOSPITAL   (United States)

^b Essex Surgical Associates   (United States)

Author keywords

CASP8; Follicular thyroid cancer; Hypermethylation; NIS; Papillary thyroid cancer; RASSF1

Indexed keywords

DNA;

ANAPLASTIC CARCINOMA; ARTICLE; ASPIRATION BIOPSY; CARCINOGENESIS; CASP8 GENE; CELL TYPE; CLINICAL ARTICLE; DNA EXTRACTION; DNA METHYLATION; EARLY DIAGNOSIS; GENE; HUMAN; HYPERTHYROIDISM; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; NIS GENE; PILOT STUDY; POLYMERASE CHAIN REACTION; PROMOTER REGION; RASSF1 GENE; THYROID CANCER; THYROID FOLLICULAR CARCINOMA; THYROID MEDULLARY CARCINOMA; THYROID PAPILLARY CARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 79959735111     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers3021732     Document Type: Article

References (49)

1. Thyroid cancer. Available online: http://www.cancer.gov/cancertopics/types/thyroid (accessed on 24 February 2011).
2. American Cancer Society. Quickfacts Thyroid Cancer; American Cancer Society: Atlanta, GA, USA, 2009.
3. Stearns, V.; Yamauchi, H.; Hayes, D.F. Circulating tumor markers in breast cancer: Accepted utilities and novel prospects. Breast Cancer Res. Treat. 1998, 52, 239-259.
4. Hu, M.I.; Vassilopoulou-Sellin, R.; Lustig, R.; Lamont, J.P. Thyroid and parathyroid cancers. In Cancer Management: A Multidisciplinary Approach, 11th ed.; Pazdur, R., Wagman, L.D, Camphausen, K.A., Hoskins, W.J., Eds.; Congregational Ministries Publishing: Louisville, KY, USA, 2008.
5. American Cancer Society. American Cancer Society Cancer Facts and Figures; American Cancer Society: Atlanta, GA, USA, 2005.
6. Weber, F.; Eng, C. Gene-expression profiling in differentiated thyroid cancer--a viable strategy for the practice of genomic medicine? Future Oncol. 2005, 1, 497-510.
7. Mazzaferri, E.L.; Kloos, R.T. Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer. J. Clin. Endocrinol. Metab. 2001, 86, 1447-1463.
8. Schlumberger, M.J. Papillary and follicular thyroid carcinoma. N. Engl. J. Med. 1998, 338, 297-306.
9. Hayes, D.F.; Bast, R.C.; Desch, C.E.; Fritsche, H., Jr.; Kemeny, N.E.; Jessup, J.M.; Locker, G.Y.; Macdonald, J.S.; Mennel, R.G.; Norton, L.; Ravdin, P.; Taube, S.; Winn, R.J. Tumor marker utility grading system: A framework to evaluate clinical utility of tumor markers. J. Natl. Cancer Inst. 1996, 88, 1456-1466.
10. Kulasingam, V.; Diamandis, E.P. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies. Nat. Clin. Pract. Oncol. 2008, 5, 588-599.
11. Xing, M. Gene methylation in thyroid tumorigenesis. Endocrinology 2007, 148, 948-953.
12. Smith, J.A.; Fan, C.Y.; Zou, C.; Bodenner, D.; Kokoska, M.S. Methylation status of genes in papillary thyroid carcinoma. Arch. Otolaryngol. Head Neck Surg. 2007, 133, 1006-1011.
13. Hu, S.; Liu, D.; Tufano, R.P.; Carson, K.A.; Rosenbaum, E.; Cohen, Y.; Holt, E.H.; Kiseljak-Vassiliades, K.; Rhoden, K.J.; Tolaney, S.; Condouris, S.; Tallini, G.; Westra, W.H.; Umbricht, C.B.; Zeiger, M.A.; Califano, J.A.; Vasko, V.; Xing, M. Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and braf mutation in papillary thyroid cancer. Int. J. Cancer 2006, 119, 2322-2329.
14. Xing, M.; Cohen, Y.; Mambo, E.; Tallini, G.; Udelsman, R.; Ladenson, P.W.; Sidransky, D. Early occurrence of rassf1a hypermethylation and its mutual exclusion with braf mutation in thyroid tumorigenesis. Cancer Res. 2004, 64, 1664-1668.
15. Lazar, V.; Bidart, J.M.; Caillou, B.; Mahe, C.; Lacroix, L.; Filetti, S.; Schlumberger, M. Expression of the na+/i- symporter gene in human thyroid tumors: A comparison study with other thyroid-specific genes. J. Clin. Endocrinol. Metab. 1999, 84, 3228-3234.
16. Xing, M.; Usadel, H.; Cohen, Y.; Tokumaru, Y.; Guo, Z.; Westra, W.B.; Tong, B.C.; Tallini, G.; Udelsman, R.; Califano, J.A.; Ladenson, P.W.; Sidransky, D. Methylation of the thyroid-stimulating hormone receptor gene in epithelial thyroid tumors: A marker of malignancy and a cause of gene silencing. Cancer Res. 2003, 63, 2316-2321.
17. Ringel, M.D.; Anderson, J.; Souza, S.L.; Burch, H.B.; Tambascia, M.; Shriver, C.D.; Tuttle, R.M. Expression of the sodium iodide symporter and thyroglobulin genes are reduced in papillary thyroid cancer. Mod. Pathol. 2001, 14, 289-296.
18. Segev, D.L.; Clark, D.P.; Zeiger, M.A.; Umbricht, C. Beyond the suspicious thyroid fine needle aspirate. A review. Acta. Cytol. 2003, 47, 709-722.
19. Sherman, S.I. Thyroid carcinoma. Lancet 2003, 361, 501-511.
20. Baloch, Z.W.; Fleisher, S.; LiVolsi, V.A.; Gupta, P.K. Diagnosis of Follicular neoplasm: A gray zone in thyroid fine-needle aspiration cytology. Diagn. Cytopathol. 2002, 26, 41-44.
21. Yeh, M.W.; Demircan, O.; Ituarte, P.; Clark, O.H. False-negative fine-needle aspiration cytology results delay treatment and adversely affect outcome in patients with thyroid carcinoma. Thyroid 2004, 14, 207-215.
22. Putti, T.C.; Bhuiya, T.A.; Wasserman, P.G. Fine needle aspiration cytology of mixed tall and columnar cell papillary carcinoma of the thyroid. A case report. Acta. Cytol. 1998, 42, 387-390.
23. Wreesmann, V.B.; Sieczka, E.M.; Socci, N.D.; Hezel, M.; Belbin, T.J.; Childs, G.; Patel, S.G.; Patel, K.N.; Tallini, G.; Prystowsky, M.; Shaha, A.R.; Kraus, D.; Shah, J.P.; Rao, P.H.; Ghossein, R.; Singh, B. Genome-wide profiling of papillary thyroid cancer identifies muc1 as an independent prognostic marker. Cancer Res. 2004, 64, 3780-3789.
24. Ruggeri, R.M.; Campenni, A.; Baldari, S.; Trimarchi, F.; Trovato, M. What is new on thyroid cancer biomarkers. Biomark. Insights 2008, 3, 237-252.
25. Pingoud-Meier, C.; Lang, D.; Janss, A.J.; Rorke, L.B.; Phillips, P.C.; Shalaby, T.; Grotzer, M.A. Loss of caspase-8 protein expression correlates with unfavorable survival outcome in childhood medulloblastoma. Clin. Cancer. Res. 2003, 9, 6401-6409.
26. Yang, Q.; Kiernan, C.M.; Tian, Y.; Salwen, H.R.; Chlenski, A.; Brumback, B.A.; London, W.B.; Cohn, S.L. Methylation of casp8, dcr2, and hin-1 in neuroblastoma is associated with poor outcome. Clin. Cancer. Res. 2007, 13, 3191-3197.
27. Harada, K.; Toyooka, S.; Shivapurkar, N.; Maitra, A.; Reddy, J.L.; Matta, H.; Miyajima, K.; Timmons, C.F.; Tomlinson, G.E.; Mastrangelo, D.; Hay, R.J.; Chaudhary, P.M.; Gazdar, A.F. Deregulation of caspase 8 and 10 expression in pediatric tumors and cell lines. Cancer Res. 2002, 62, 5897-5901.
28. Wu, Y.; Alvarez, M.; Slamon, D.J.; Koeffler, P.; Vadgama, J.V. Caspase 8 and maspin are downregulated in breast cancer cells due to cpg site promoter methylation. BMC Cancer 2010, 10, 32.
29. Ho, P.K.; Hawkins, C.J. Mammalian initiator apoptotic caspases. Febs. J. 2005, 272, 5436-5453.
30. Teitz, T.; Wei, T.; Valentine, M.B.; Vanin, E.F.; Grenet, J.; Valentine, V.A.; Behm, F.G.; Look, A.T.; Lahti, J.M.; Kidd, V.J. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of mycn. Nat. Med. 2000, 6, 529-535.
31. Fulda, S.; Debatin, K.M. Ifngamma sensitizes for apoptosis by upregulating caspase-8 expression through the stat1 pathway. Oncogene 2002, 21, 2295-2308.
32. Liedtke, C.; Groger, N.; Manns, M.P.; Trautwein, C. The human caspase-8 promoter sustains basal activity through sp1 and ets-like transcription factors and can be up-regulated by a p53-dependent mechanism. J. Biol. Chem. 2003, 278, 27593-27604.
33. Chaudhary, P.M.; Eby, M.T.; Jasmin, A.; Kumar, A.; Liu, L.; Hood, L. Activation of the nf-kappab pathway by caspase 8 and its homologs. Oncogene 2000, 19, 4451-4460.
34. Salvesen, G.S. Caspase 8: Igniting the death machine. Structure 1999, 7, R225-R229.
35. Zoli, W.; Ulivi, P.; Tesei, A.; Fabbri, F.; Rosetti, M.; Maltoni, R.; Giunchi, D.C.; Ricotti, L.; Brigliadori, G.; Vannini, I.; Amadori, D. Addition of 5-fluorouracil to doxorubicin-paclitaxel sequence increases caspase-dependent apoptosis in breast cancer cell lines. Breast Cancer Res. 2005, 7, R681-R689.
36. Ehrhardt, H.; Hacker, S.; Wittmann, S.; Maurer, M.; Borkhardt, A.; Toloczko, A.; Debatin, K.M.; Fulda, S.; Jeremias, I. Cytotoxic drug-induced, p53-mediated upregulation of caspase-8 in tumor cells. Oncogene 2008, 27, 783-793.
37. Schagdarsurengin, U.; Gimm, O.; Hoang-Vu, C.; Dralle, H.; Pfeifer, G.P.; Dammann, R. Frequent epigenetic silencing of the cpg island promoter of rassf1a in thyroid carcinoma. Cancer Res. 2002, 62, 3698-3701.
38. Hou, P.; Bojdani, E.; Xing, M. Induction of thyroid gene expression and radioiodine uptake in thyroid cancer cells by targeting major signaling pathways. J. Clin. Endocrinol. Metab. 2010, 95, 820-828.
39. Venkataraman, G.M.; Yatin, M.; Marcinek, R.; Ain, K.B. Restoration of iodide uptake in dedifferentiated thyroid carcinoma: Relationship to human na+/i-symporter gene methylation status. J. Clin. Endocrinol. Metab. 1999, 84, 2449-2457.
40. Boltze, C.; Zack, S.; Quednow, C.; Bettge, S.; Roessner, A.; Schneider-Stock, R. Hypermethylation of the cdkn2/p16ink4a promotor in thyroid carcinogenesis. Pathol. Res. Pract. 2003, 199, 399-404.
41. Smanik, P.A.; Ryu, K.Y.; Theil, K.S.; Mazzaferri, E.L.; Jhiang, S.M. Expression, exon-intron organization, and chromosome mapping of the human sodium iodide symporter. Endocrinology 1997, 138, 3555-3558.
42. Arturi, F.; Russo, D.; Schlumberger, M.; du Villard, J.A.; Caillou, B.; Vigneri, P.; Wicker, R.; Chiefari, E.; Suarez, H.G.; Filetti, S. Iodide symporter gene expression in human thyroid tumors. J. Clin. Endocrinol. Metab. 1998, 83, 2493-2496.
43. Filetti, S.; Bidart, J.M.; Arturi, F.; Caillou, B.; Russo, D.; Schlumberger, M. Sodium/iodide symporter: A key transport system in thyroid cancer cell metabolism. Eur. J. Endocrinol. 1999, 141, 443-457.
44. Stephen, J.K.; Vaught, L.E.; Chen, K.M.; Sethi, S.; Shah, V.; Benninger, M.S.; Gardner, G.M.; Schweitzer, V.G.; Khan, M.; Worsham, M.J. Epigenetic events underlie the pathogenesis of sinonasal papillomas. Mod. Pathol. 2007, 20, 1019-1027.
45. Stephen, J.K.; Chen, K.M.; Shah, V.; Schweitzer, V.G.; Gardner, G.; Benninger, M.S.; Worsham, M.J. Consistent DNA hypermethylation patterns in laryngeal papillomas. Int. J. Head Neck Surg. 2010, 1, 69-77.
46. Nygren, A.O.; Ameziane, N.; Duarte, H.M.; Vijzelaar, R.N.; Waisfisz, Q.; Hess, C.J.; Schouten, J.P.; Errami, A. Methylation-specific mlpa (ms-mlpa): Simultaneous detection of cpg methylation and copy number changes of up to 40 sequences. Nucleic Acids Res. 2005, 33, e128.
47. Stephen, J.K.; Vaught, L.E.; Chen, K.M.; Shah, V.; Schweitzer, V.G.; Gardner, G.; Benninger, M.S.; Worsham, M.J. An epigenetically derived monoclonal origin for recurrent respiratory papillomatosis. Arch. Otolaryngol. Head Neck Surg. 2007, 133, 684-692.
48. Worsham, M.J.; Chen, K.M.; Meduri, V.; Nygren, A.O.; Errami, A.; Schouten, J.P.; Benninger, M.S. Epigenetic events of disease progression in head and neck squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg. 2006, 132, 668-677.
49. Chen, K.; Sawhney, R.; Khan, M.; Benninger, M.S.; Hou, Z.; Sethi, S.; Stephen, J.K.; Worsham, M.J. Methylation of multiple genes as diagnostic and therapeutic markers in primary head and neck squamous cell carcinoma. Arch. Otolaryngol. Head Neck Surg. 2007, 133, 1131-1138.